
Key facts
- Company
- Eli Lilly and Company
- Location
- Houston, Texas, United States — Generation Park
- Announced
- September 21, 2026
- Stage
- Groundbreaking
- Jobs
- +600 jobs — more than 600 permanent high-wage jobs and 4,000 construction jobs
- Investment
- $6.5 billion
- Public incentives
- Texas JETI program; Texas Enterprise Fund grant of $5.5 million
- Timeline
- groundbreaking 21 Sep 2026; opening year not stated
- Facility
- active pharmaceutical ingredients, including for orforglipron (Foundayo)
- Source confidence
- primary source confirmed
What happened
Eli Lilly broke ground on September 21, 2026, on a $6.5 billion plant at Generation Park in Houston that will make active pharmaceutical ingredients. The company says the site will create more than 600 high-wage jobs and 4,000 construction jobs. Texas Governor Greg Abbott spoke at the groundbreaking; his office called it the largest active pharmaceutical ingredient project in Texas history.
The plant, in Harris County, will make ingredients for Foundayo (orforglipron), Lilly's oral GLP-1 medicine, as well as other small-molecule medicines, advanced therapeutics and oligonucleotides. Lilly describes Houston as one of ten U.S. manufacturing sites it has announced since 2020, part of a broader $50 billion U.S. manufacturing program.
The groundbreaking is not the first news about the site. Secondary reports say Lilly first announced the Houston project about a year earlier; we did not confirm the original date. The September event marks the start of construction.
Texas backed the project through its JETI program and a $5.5 million Texas Enterprise Fund grant, the governor's office said. Lilly's release does not give an opening date. Axios Houston and CultureMap Houston also covered the groundbreaking.
What this means for job seekers
Company confirmed
- More than 600 high-wage jobs at the finished plant.
- 4,000 construction jobs during the build.
- Location: Generation Park, Houston, in Harris County.
Potential impact Inference
- The construction jobs are likely to come first, mostly through contractors rather than Lilly itself.
- Permanent manufacturing roles are likely to be posted in stages as the plant nears operation. Lilly has not published dates.
Our reading of the announcement, not a statement by the company.
Jobs and occupations
- pharmaceutical manufacturing techniciansinference
- process engineersinference
- quality control analystsinference
- construction tradesinference
Related listings on Global Work AI:process engineersquality control analysts
Current jobs at Eli Lilly and Company
Global Work AI jobs data, as of Nov 16, 2026 · 564 open jobs
TodayLilly
Engineer
Provide process engineering support for GMP manufacturing of commercial cell banks and development bioassays. Collaborate with engineering vendors and maintenance staff to ensure reliable cGMP manufacturing. Prepare technical documents including Equipment Qualifications and Deviation Investigations.
onsite, Indpls, IN, United States
$68k/yr
Full Time
Junior (<2 years)
TodayLilly
Associate director/director, pharmacovigilance scientist team leader, global patient safety
Lead a team of Pharmacovigilance Scientists, overseeing workload management, performance evaluations, and career development. Ensure timely signal detection, safety data evaluation, and regulatory compliance.
onsite, Indpls, IN, United States
$84k – $123k/yr
Full Time
Lead / Manager
TodayLilly
Associate director – process control & automation engineering
Supervise process control engineers and technicians, ensuring reliable control applications in API manufacturing. Drive automation infrastructure evolution toward Industry 4.0 standards and lead cross-functional teams in DCS, PLC, SCADA, and batch automation.
onsite, Lebanon, IL, United States
$123k – $180k/yr
Full Time
Director
TodayLilly
Associate director - cfib deal enablement & operations
Define and implement processes, standards, and tools for Corporate Finance & Investment Banking (CFIB). Partner with CFIB and external advisors to support deal execution. Lead strategy and transformation projects, incorporating AI and automation into workflows.
onsite, Indpls, IN, United States
$132k – $194k/yr
Full Time
Director
TodayLilly
Sr. advisor - statistics
Develop and assist in protocol designs, clinical plans, and data analysis plans. Select statistical methods for data analysis, author protocol sections, and conduct analyses. Collaborate on data quality assurance plans and communicate study results through reports and presentations.
onsite, Indpls, IN, United States
$153k – $246k/yr
Full Time
Senior (5+ years)
About Eli Lilly and Company
- Eli Lilly and CompanyPharmaceutical Manufacturing · HQ Lilly Corporate Center, Indianapolis, Indiana 46285, US · 564 open jobs as of Nov 16, 2026
Sources
- Primary sourceEli Lilly and Company (PR Newswire) — “Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020”, prnewswire.com
- Primary sourceOffice of the Texas Governor — “Governor Abbott Delivers Remarks At Lilly Groundbreaking In Houston”, gov.texas.gov
- Independent reportAxios — “Eli Lilly breaks ground on $6.5B pharmaceutical manufacturing plant in Houston”, axios.com
- Independent reportCultureMap Houston — “Eli Lilly breaks ground on $6.5 billion Houston pharmaceutical plant”, houston.culturemap.com


